Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Rating) saw a significant growth in short interest in the month of March. As of March 31st, there was short interest totalling 1,050,000 shares, a growth of 17.6% from the March 15th total of 892,900 shares. Based on an average daily trading volume, of 84,200 shares, the days-to-cover […]
Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Rating)’s share price passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $7.19 and traded as high as $8.10. Alpine Immune Sciences shares last traded at $8.09, with a volume of 62,603 shares traded. Analyst Upgrades and Downgrades […]
Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Rating) – Equities research analysts at Wedbush issued their Q1 2024 EPS estimates for Alpine Immune Sciences in a research note issued to investors on Friday, March 24th. Wedbush analyst R. Driscoll anticipates that the biotechnology company will post earnings per share of ($0.23) for the quarter. Wedbush […]
Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Rating) – Oppenheimer issued their Q1 2024 earnings per share estimates for shares of Alpine Immune Sciences in a research note issued to investors on Friday, March 24th. Oppenheimer analyst M. Breidenbach expects that the biotechnology company will post earnings of ($0.41) per share for the quarter. The […]
Alpine Immune Sciences (NASDAQ:ALPN – Get Rating) had its price objective increased by HC Wainwright from $8.00 to $11.00 in a research report report published on Friday morning, The Fly reports. HC Wainwright also issued estimates for Alpine Immune Sciences’ Q2 2023 earnings at ($0.35) EPS and Q3 2023 earnings at ($0.39) EPS. Separately, Morgan […]